메뉴 건너뛰기




Volumn 6, Issue 2, 2011, Pages 157-171

Pathophysiological mechanisms in antiphospholipid syndrome

Author keywords

annexin; anti 2 glycoprotein I antibody; antiphospholipid antibodies; antiphospholipid syndrome; endothelial cell activation; pathogenesis; platelet activation; pregnancy loss; thrombosis; treatment

Indexed keywords

ANNEXIN; B CELL ACTIVATING FACTOR; BETA2 GLYCOPROTEIN 1; BETA2 GLYCOPROTEIN 1 ANTIBODY; FLUINDOSTATIN; HYDROXYCHLOROQUINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPOCORTIN 5; MITOGEN ACTIVATED PROTEIN KINASE P38; PEPTIDE; PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTHROMBIN ANTIBODY; RECOMBINANT DOMAIN 1 PEPTIDE; SIMVASTATIN; THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

EID: 79955062291     PISSN: 17584272     EISSN: None     Source Type: Journal    
DOI: 10.2217/ijr.11.9     Document Type: Review
Times cited : (26)

References (138)
  • 1
    • 0023434038 scopus 로고
    • Syndrome of the black swan
    • Harris E: Syndrome of the black swan. Br. J. Rheumatol. 26(5), 324-326 (1987).
    • (1987) Br. J. Rheumatol. , vol.26 , Issue.5 , pp. 324-326
    • Harris, E.1
  • 3
    • 33344458573 scopus 로고    scopus 로고
    • International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome APS
    • Miyakis S, Lockshin M, Atusmi T et al.: International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).J. Thromb. Haemost. 4, 295-306 (2006).
    • (2006) J. Thromb. Haemost. , vol.4 , pp. 295-306
    • Miyakis, S.1    Lockshin, M.2    Atusmi, T.3
  • 4
    • 0023772539 scopus 로고
    • Antiprothrombin antibodies and the lupus anticoagulant
    • Fleck R, Rapaport S, Rao L: Antiprothrombin antibodies and the lupus anticoagulant. Blood 72(2), 512-519 (1988).
    • (1988) Blood , vol.72 , Issue.2 , pp. 512-519
    • Fleck, R.1    Rapaport, S.2    Rao, L.3
  • 5
    • 0025332717 scopus 로고
    • Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β2-glycoprotein I apolipoprotein H
    • USA
    • McNeil H, Simpson R, Chesterman C, Krilis S: Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β2-glycoprotein I (apolipoprotein H).Proc. Natl Acad. Sci. USA 87, 4120-4124 (1990).
    • (1990) Proc. Natl Acad. Sci. , vol.87 , pp. 4120-4124
    • McNeil, H.1    Simpson, R.2    Chesterman, C.3    Krilis, S.4
  • 6
    • 33748550680 scopus 로고    scopus 로고
    • 2-glycoprotein I: Prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus
    • Danowski A, Kickler T, Petri M: Anti-β2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus. J. Rheumatol. 33(9), 1775-1779 (2006). (Pubitemid 44373210)
    • (2006) Journal of Rheumatology , vol.33 , Issue.9 , pp. 1775-1779
    • Danowski, A.1    Kickler, T.S.2    Petri, M.3
  • 7
    • 34248523994 scopus 로고    scopus 로고
    • 2-glycoprotein I and the homologous catalytic domains of several serine proteases
    • DOI 10.1002/art.22522
    • Lin W-S, Chen P-C, Yang C-D et al.: Some antiphospholipid antibodies recognize conformational epitopes shared by β2-glycoprotein I and the homologous catalytic domains of several serine proteases. Arthritis Rheum. 56(5), 1638-1647 (2007). (Pubitemid 46764093)
    • (2007) Arthritis and Rheumatism , vol.56 , Issue.5 , pp. 1638-1647
    • Lin, W.-S.1    Chen, P.-C.2    Yang, C.-B.3    Cho, E.4    Hahn, B.H.5    Grossman, J.6    Hwang, K.-K.7    Chen, P.P.8
  • 8
    • 61449186513 scopus 로고    scopus 로고
    • Risk factors for a first thrombotic event in antiphospholipid antibody carriers a multicentre retrospective follow-up study
    • Ruffatti A, Del Ross T, Ciprian M et al.: Risk factors for a first thrombotic event in antiphospholipid antibody carriers. A multicentre, retrospective follow-up study. Ann. Rheum. Dis. 68, 397-399 (2009).
    • (2009) Ann. Rheum. Dis. , vol.68 , pp. 397-399
    • Ruffatti, A.1    Del Ross, T.2    Ciprian, M.3
  • 9
    • 67149087369 scopus 로고    scopus 로고
    • Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus
    • Danowski A, de Azevedo M, de Souza Papi J, Petri M: Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus. J. Rheumatol. 36, 1195-1199 (2009).
    • (2009) J. Rheumatol. , vol.36 , pp. 1195-1199
    • Danowski, A.1    De Azevedo, M.2    De Souza Papi, J.3    Petri, M.4
  • 10
    • 0037370733 scopus 로고    scopus 로고
    • Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: A systematic review of the literature
    • DOI 10.1182/blood-2002-02-0441
    • Galli M, Luciani D, Bertolini G, Barbui T: Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 101(5), 1827-1832 (2003). (Pubitemid 36237580)
    • (2003) Blood , vol.101 , Issue.5 , pp. 1827-1832
    • Galli, M.1    Luciani, D.2    Bertolini, G.3    Barbui, T.4
  • 12
    • 67649371944 scopus 로고    scopus 로고
    • Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: A multicentre prospective study of 1000 patients
    • Cervera R, Khamashta M, Shoenfeld Y et al.: Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients. Ann. Rheum. Dis. 68, 1428-1432 (2009).
    • (2009) Ann. Rheum. Dis. , vol.68 , pp. 1428-1432
    • Cervera, R.1    Khamashta, M.2    Shoenfeld, Y.3
  • 14
    • 33344456904 scopus 로고    scopus 로고
    • 2-glycoprotein I only after a conformational change
    • DOI 10.1182/blood-2005-05-1943
    • de Laat B, Derksen R, Lummel M, Pennings M, de Groot P: Pathogenic anti-β2-glycoprotein I antibodies recognize domain I of the β2-glycoprotein I only after a conformational change. Blood 107, 1916-1924 (2006). (Pubitemid 43289372)
    • (2006) Blood , vol.107 , Issue.5 , pp. 1916-1924
    • De Laat, B.1    Derksen, R.H.W.M.2    Van Lummel, M.3    Pennings, M.T.T.4    De Groot, P.G.5
  • 15
    • 13544276197 scopus 로고    scopus 로고
    • 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis
    • DOI 10.1182/blood-2004-09-3387
    • de Laat B, Derksen R, Urbanus R, de Groot P: IgG antibodies that recognize epitope Gly40-Arg43 in domain I of β2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis. Blood 105, 1540-1545 (2005). (Pubitemid 40223671)
    • (2005) Blood , vol.105 , Issue.4 , pp. 1540-1545
    • De Laat, B.1    Derksen, R.H.W.M.2    Urbanus, R.T.3    De Groot, P.G.4
  • 16
    • 33846236309 scopus 로고    scopus 로고
    • Binding of antiphospholipid antibodies to discontinuous epitopes on domain I of human β2-glycoprotein I
    • Ioannou Y, Pericleous C, Giles I, Latchman D, Isenberg D, Rahman A: Binding of antiphospholipid antibodies to discontinuous epitopes on domain I of human β2-glycoprotein I. Arthritis Rheum. 56(1), 280-290 (2007).
    • (2007) Arthritis Rheum. , vol.56 , Issue.1 , pp. 280-290
    • Ioannou, Y.1    Pericleous, C.2    Giles, I.3    Latchman, D.4    Isenberg, D.5    Rahman, A.6
  • 17
    • 77956488547 scopus 로고    scopus 로고
    • β2-Glycoprotein I can exist in 2 conformations: Implications for our understanding of the antiphospholipid syndrome
    • Agar C, van Os G, Morgelin M et al.: β2-glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome. Blood 116, 1336-1343 (2010).
    • (2010) Blood , vol.116 , pp. 1336-1343
    • Agar, C.1    Van Os, G.2    Morgelin, M.3
  • 18
    • 5444256422 scopus 로고    scopus 로고
    • Beta-2-glycoprotein specificity of human anti-phospholipid antibody resides on the light chain: A novel mechanism for acquisition of cross-reactivity by an autoantibody
    • DOI 10.1016/j.molimm.2004.07.012, PII S0161589004002743
    • Kumar S, Nagl S, Kalsi J et al.: b-2-glycoprotein specificity of human anti-phospholipid antibody resides on the light chain: a novel mechanism for acquisitionof cross-reactivity by an autoantibody. Mol. Immunol. 42, 39-48 (2004). (Pubitemid 39360925)
    • (2005) Molecular Immunology , vol.42 , Issue.1 , pp. 39-48
    • Kumar, S.1    Nagl, S.2    Kalsi, J.K.3    Ravirajan, C.T.4    Athwal, D.5    Latchman, D.S.6    Pearl, L.H.7    Isenberg, D.A.8
  • 19
    • 0033173789 scopus 로고    scopus 로고
    • 247 polymorphism and anti-β2-glycoprotein I antibodies in patients with primary antiphospholipid syndrome
    • DOI 10.1093/rheumatology/38.8.721
    • Atsumi T, Tsutsumi A, Amengual O et al.: Correlation between β2-glycoprotein I valine/ leucine 247 polymorphism and anti-β2- glycoprotein I antibodies in patients with primary antiphospholipid syndrome. Rheumatology 38(8), 721-723 (1999). (Pubitemid 29507387)
    • (1999) Rheumatology , vol.38 , Issue.8 , pp. 721-723
    • Atsumi, T.1    Tsutsumi, A.2    Amengual, O.3    Khamashta, M.A.4    Hughes, G.R.V.5    Miyoshi, Y.6    Ichikawa, K.7    Koike, T.8
  • 20
    • 12344312949 scopus 로고    scopus 로고
    • Significance of valine leucine 247polymorphism of β2-glycoprotein I in antiphospholipid syndrome: Increased reactivity of anti-β2-glycoprotein I autoantibodies to the valine 247 β2- glycoprotein I variant
    • Yasuda S, Atusmi T, Matsuura E et al.: Significance of valine/leucine 247polymorphism of β2- glycoprotein I in antiphospholipid syndrome: increased reactivity of anti-β2-glycoprotein I autoantibodies to the valine 247 β2- glycoprotein I variant. Arthritis Rheum. 52(1), 212-218 (2005).
    • (2005) Arthritis Rheum. , vol.52 , Issue.1 , pp. 212-218
    • Yasuda, S.1    Atusmi, T.2    Matsuura, E.3
  • 22
    • 69949179178 scopus 로고    scopus 로고
    • Val Leu247 polymorphism of β2-glycoprotein I in brazilian patients with antiphospholipid syndrome -a genetic risk factor
    • Pernambuco-Climaco J, Brochado M, Frietas M, Roselino A, Louzado-Junior P: Val/ Leu247 polymorphism of β2-glycoprotein I in Brazilian patients with antiphospholipid syndrome - a genetic risk factor? Ann. NY Acad. Sci. 1173, 509-514 (2009).
    • (2009) Ann. NY Acad. Sci. , vol.1173 , pp. 509-514
    • Pernambuco-Climaco, J.1    Brochado, M.2    Frietas, M.3    Roselino, A.4    Louzado-Junior, P.5
  • 23
    • 70449390005 scopus 로고    scopus 로고
    • The association between circulating antibodies against domain I of β2- glycoprotein I and thrombosis: An international multicenter study
    • de Laat B, Pengo V, Pabinger I et al.: The association between circulating antibodies against domain I of β2- glycoprotein I and thrombosis: an international multicenter study. J. Thromb. Haemost. 7, 1767-1773 (2009).
    • (2009) J. Thromb. Haemost. , vol.7 , pp. 1767-1773
    • De Laat, B.1    Pengo, V.2    Pabinger, I.3
  • 24
    • 33847055815 scopus 로고    scopus 로고
    • β2-glycoprotein I binds thrombin via exosite I and exosite II: anti-β2-glycoprotein I antibodies potentiate the inhibitory effect of β2-glycoprotein I on thrombin-mediated factor XIa generation
    • Rahgozar S, Yang Q, Giannakopoulos B, Yan X, Miyakis S, Krilis S: β2-glycoprotein I binds thrombin via exosite I and exosite II: anti-β2-glycoprotein I antibodies potentiate the inhibitory effect of β2-glycoprotein I on thrombin-mediated factor XIa generation. Arthritis Rheum. 56(2), 605-613 (2007).
    • (2007) Arthritis Rheum. , vol.56 , Issue.2 , pp. 605-613
    • Rahgozar, S.1    Yang, Q.2    Giannakopoulos, B.3    Yan, X.4    Miyakis, S.5    Krilis, S.6
  • 28
    • 0141445991 scopus 로고    scopus 로고
    • 2-Glycoprotein I Increase Platelet Deposition to Collagen via Interaction with Phospholipids and the Apolipoprotein E Receptor 2β
    • DOI 10.1074/jbc.M212655200
    • Lutters B, Derksen R, Tekelenburg W, Lenting P, Arnout J, de Groot P: Dimers of β2-glycoprotein I increase platelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 2́. J. Biol. Chem. 278(36), 33831-33838 (2003). (Pubitemid 37553217)
    • (2003) Journal of Biological Chemistry , vol.278 , Issue.36 , pp. 33831-33838
    • Lutters, B.C.H.1    Derksen, R.H.W.M.2    Tekelenburg, W.L.3    Lenting, P.J.4    Arnout, J.5    De Groot, P.G.6
  • 29
    • 79251578627 scopus 로고    scopus 로고
    • Apolipoprotein E receptor 2́ is involved in the thrombotic complications in a murine model of the antiphospholipid syndrome
    • Romay-Penabad Z, Aguilar-Valenzuela R, Urbanus R et al.: Apolipoprotein E receptor 2́ is involved in the thrombotic complications in a murine model of the antiphospholipid syndrome. Blood 117(4), 1408-1414 (2011).
    • (2011) Blood , vol.117 , Issue.4 , pp. 1408-1414
    • Romay-Penabad, Z.1    Aguilar-Valenzuela, R.2    Urbanus, R.3
  • 30
    • 46749138272 scopus 로고    scopus 로고
    • Anti-annexin II antibodies in systemic autoimmune disease and antiphospholipid syndrome
    • Salle V, Maziere J, Smail A et al.: Anti-annexin II antibodies in systemic autoimmune disease and antiphospholipid syndrome. J. Clin. Immunol. 28, 291-297 (2008).
    • (2008) J. Clin. Immunol. , vol.28 , pp. 291-297
    • Salle, V.1    Maziere, J.2    Smail, A.3
  • 31
    • 70350786142 scopus 로고    scopus 로고
    • Annexin A2 mediates anti-b2GPI b2GPI-induced tissue factor expression on monocytes
    • Zhou H, Wang H, Li N et al.: Annexin A2 mediates anti-b2GPI/b2GPI-induced tissue factor expression on monocytes. Int. J. Mol. Med. (24), 557-562 (2009).
    • (2009) Int. J. Mol. Med. , vol.24 , pp. 557-562
    • Zhou, H.1    Wang, H.2    Li, N.3
  • 32
    • 0028129557 scopus 로고
    • An endothelial cell receptor for plasminogen tissue plasminogen activator t-PA
    • Cesarman G, Guevara C, Hajjar K: An endothelial cell receptor for plasminogen/ tissue plasminogen activator (t-PA).J. Biol. Chem. 269(33), 21198-21203 (1994).
    • (1994) J. Biol. Chem. , vol.269 , Issue.33 , pp. 21198-21203
    • Cesarman, G.1    Guevara, C.2    Hajjar, K.3
  • 34
    • 70449509134 scopus 로고    scopus 로고
    • Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo
    • Romay-Penabad Z, Montiel-Manzano M, Shilagard T et al.: Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo. Blood 114, 3074-3083 (2009).
    • (2009) Blood , vol.114 , pp. 3074-3083
    • Romay-Penabad, Z.1    Montiel-Manzano, M.2    Shilagard, T.3
  • 35
    • 50349088997 scopus 로고    scopus 로고
    • Endothelial cell annexin A2 regulates polyubiquitination and degradation of its binding partner S100A10 p11
    • He K, Deora A, Xiong H et al.: Endothelial cell annexin A2 regulates polyubiquitination and degradation of its binding partner S100A10/p11. J. Biol. Chem. 283(28), 19192-19200 (2008).
    • (2008) J. Biol. Chem. , vol.283 , Issue.28 , pp. 19192-19200
    • He, K.1    Deora, A.2    Xiong, H.3
  • 36
    • 14944367961 scopus 로고    scopus 로고
    • 2 glycoprotein I antibodies
    • DOI 10.1182/blood-2004-05-1708
    • Zhang J, McCrae K: Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-β-2 glycoprotein I antibodies. Blood 105, 1964-1969 (2005). (Pubitemid 40731779)
    • (2005) Blood , vol.105 , Issue.5 , pp. 1964-1969
    • Zhang, J.1    McCrae, K.R.2
  • 37
    • 77953624768 scopus 로고    scopus 로고
    • Effects of polyclonal IgG derived from patients with different clinical types of the antiphospholipid syndrome on monocyte signalling pathways
    • Lambrianides A, Carroll C, Pierangeli S et al.: Effects of polyclonal IgG derived from patients with different clinical types of the antiphospholipid syndrome on monocyte signalling pathways. J. Immunol. 184, 6622-6628 (2010).
    • (2010) J. Immunol. , vol.184 , pp. 6622-6628
    • Lambrianides, A.1    Carroll, C.2    Pierangeli, S.3
  • 38
    • 33846899419 scopus 로고    scopus 로고
    • The role of TLR2 in the inflammatory activation of mouse fibroblasts by human antiphospholipid antibodies
    • DOI 10.1182/blood-2005-03-024463
    • Satta N, Dunoyer-Geindre S, Reber G et al.: The role of TLR2 in the inflammatory activation of mouse fibroblasts by human antiphospholipid antibodies. Blood 109, 1507-1514 (2007). (Pubitemid 46239583)
    • (2007) Blood , vol.109 , Issue.4 , pp. 1507-1514
    • Satta, N.1    Dunoyer-Geindre, S.2    Reber, G.3    Fish, R.J.4    Boehlen, F.5    Kruithof, E.K.O.6    De Moerloose, P.7
  • 40
    • 69649095448 scopus 로고    scopus 로고
    • β2-Glycoprotein I and annexin A5 phospholipid interactions: Artificial and cell membranes
    • Frank M, Sodin-Semri S, Irman S, Bozic B, Rozman B: β2-glycoprotein I and annexin A5 phospholipid interactions: artificial and cell membranes. Autoimmun. Rev. 9, 5-10 (2009).
    • (2009) Autoimmun. Rev. , vol.9 , pp. 5-10
    • Frank, M.1    Sodin-Semri, S.2    Irman, S.3    Bozic, B.4    Rozman, B.5
  • 41
    • 7244242660 scopus 로고    scopus 로고
    • Intracellular signaling triggered by antiphospholipid antibodies in platelets and endothelial cells: A pathway to targeted therapies
    • DOI 10.1016/j.thromres.2004.06.031, PII S0049384804003408
    • Pierangeli S, Vega-Ostertag M, Harris E: Intracellular signaling triggerd by antiphospholipid antibodies in platelets and endothelial cells: a pathway to targeted therapies. Thromb. Res. 114, 467-476 (2004). (Pubitemid 39429425)
    • (2004) Thrombosis Research , vol.114 , Issue.5-6 SPEC. ISS. , pp. 467-476
    • Pierangeli, S.S.1    Vega-Ostertag, M.2    Nigel Harris, E.3
  • 42
    • 33644868952 scopus 로고    scopus 로고
    • Resistance to annexin A5 binding and anticoagulant activity in plasmas from patients with the antiphospholipid syndrome but not with syphilis
    • Wu X, Pierangeli S, Rand J: Resistance to annexin A5 binding and anticoagulant activity in plasmas from patients with the antiphospholipid syndrome but not with syphilis. J. Thromb. Haemost. 4, 271-273 (2006).
    • (2006) J. Thromb. Haemost. , vol.4 , pp. 271-273
    • Wu, X.1    Pierangeli, S.2    Rand, J.3
  • 43
    • 33846936761 scopus 로고    scopus 로고
    • Correlation between antiphospholipid antibodies that recognize domain I of β2-glycoprotein I and a reduction in the anticoagulant activity of annexin A5
    • DOI 10.1182/blood-2006-07-030148
    • de Laat B, Wu X, van Lummel M, Derksen R, de Groot P, Rand J: Correlation between antiphospholipid antibodies that recognize domain I of β2-glycoprotein I and a reduction in the anticoagulant activity of annexin A5. Blood 109, 1490-1494 (2007). (Pubitemid 46239580)
    • (2007) Blood , vol.109 , Issue.4 , pp. 1490-1494
    • De Laat, B.1    Wu, X.-X.2    Van Lummel, M.3    Derksen, R.H.W.M.4    De Groot, P.G.5    Rand, J.H.6
  • 44
    • 77950435764 scopus 로고    scopus 로고
    • Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: Evidence for a novel effect for an old anitmalarial drug
    • Rand J, Wu X, Quinn A et al.: Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old anitmalarial drug. Blood 115, 2292-2299 (2010).
    • (2010) Blood , vol.115 , pp. 2292-2299
    • Rand, J.1    Wu, X.2    Quinn, A.3
  • 45
    • 48749104624 scopus 로고    scopus 로고
    • Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-β2-glycoprotein I complexes to phospholipid bilayers
    • Rand J, Wu X, Quinn A, Chen P, Hathcock J, Taatjes D: Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-β2-glycoprotein I complexes to phospholipid bilayers. Blood 112, 1687-1695 (2008).
    • (2008) Blood , vol.112 , pp. 1687-1695
    • Rand, J.1    Wu, X.2    Quinn, A.3    Chen, P.4    Hathcock, J.5    Taatjes, D.6
  • 46
    • 51849152401 scopus 로고    scopus 로고
    • Proteomic analysis in monocytes of antiphospholipid syndrome patients: Deregulation of proteins related to the development of thrombosis
    • Lopez-Pedrera C, Cuadrado M, Hernandez V et al.: Proteomic analysis in monocytes of antiphospholipid syndrome patients: deregulation of proteins related to the development of thrombosis. Arthritis Rheum. 58(9), 2835-2844 (2006).
    • (2006) Arthritis Rheum. , vol.58 , Issue.9 , pp. 2835-2844
    • Lopez-Pedrera, C.1    Cuadrado, M.2    Hernandez, V.3
  • 47
    • 31044449865 scopus 로고    scopus 로고
    • Antiphospholipid antibodies from patients with the antiphospholipid syndrome induce monocyte tissue factor expression through the simultaneous activation of NF-kB/Rel proteins via the p38 mitogen-activated protein kinase pathway, and of the MEK-1/ERK pathway
    • DOI 10.1002/art.21549
    • Lopez-Pedrera C, Buendia P, Cuadrado M et al.: Antiphospholipid antibodies from patients with the antiphospholipid syndrome induce monocyte tissue factor expression through the simultaneous activation of NF-kB/Rel proteins via the p38 mitogenactivated protein kinase pathway, and of the MEK-1/ERK pathway. Arthritis Rheum. 54(1), 301-311 (2006). (Pubitemid 43122214)
    • (2006) Arthritis and Rheumatism , vol.54 , Issue.1 , pp. 301-311
    • Lopez-Pedrera, C.1    Buendia, P.2    Cuadrado, M.J.3    Siendones, E.4    Aguirre, M.A.5    Barbarroja, N.6    Montiel-Duarte, C.7    Torres, A.8    Khamashta, M.9    Velasco, F.10
  • 51
    • 77649099693 scopus 로고    scopus 로고
    • Differential expression of proteaseactivated receptors in monocytes from patients with primary antiphospholipid syndrome
    • Lopez-Pedrera C, Aguirre M, Buendia P et al.: Differential expression of proteaseactivated receptors in monocytes from patients with primary antiphospholipid syndrome. Arthritis Rheum. 62, 869-877 (2010).
    • (2010) Arthritis Rheum. , vol.62 , pp. 869-877
    • Lopez-Pedrera, C.1    Aguirre, M.2    Buendia, P.3
  • 52
    • 37749045374 scopus 로고    scopus 로고
    • Platelet activation rather than endothelial injury identifies risk of thrombosis in subjects positive for antiphospholipid antibodies
    • Jy W, Tiede M, Bidot C et al.: Platelet activation rather than endothelial injury identifies risk of thrombosis in subjects positive for antiphospholipid antibodies. Thromb. Res. 121, 319-325 (2007).
    • (2007) Thromb. Res. , vol.121 , pp. 319-325
    • Jy, W.1    Tiede, M.2    Bidot, C.3
  • 53
    • 45149103015 scopus 로고    scopus 로고
    • Double heterozygosity polymorphisms for platelet glycoproteins Ia/IIa and IIb/IIIa increases arterial thrombosis and arteriosclerosis in patients with the antiphospholipid syndrome or with systemic lupus erythematosus
    • DOI 10.1136/ard.2007.077321
    • Jimenez S, Tassies D, Espinosa G et al.: Double heterozygosity polymorphisms for platelet glycoproteins Ia/IIa and IIb/IIIa increases arterial thrombosis and arteriosclerosis in patients with antiphospholipid syndrome or with systemic lupus erythematosus. Ann. Rheum. Dis. 67, 835-840 (2008). (Pubitemid 351829385)
    • (2008) Annals of the Rheumatic Diseases , vol.67 , Issue.6 , pp. 835-840
    • Jimenez, S.1    Tassies, D.2    Espinosa, G.3    Garcia-Criado, A.4    Plaza, J.5    Monteagudo, J.6    Cervera, R.7    Reverter, J.C.8
  • 54
    • 47649130477 scopus 로고    scopus 로고
    • 2-glycoprotein I requires signaling via both glycoprotein Ibα and apolipoprotein E receptor 2β
    • DOI 10.1111/j.1538-7836.2008.03021.x
    • Urbanus R, Pennings M, Derksen R, de Groot P: Platelet activation by dimeric β2-glycoprotein I requires signaling via both glycoprotein Iba and apolipoprotein E receptor 2́. J. Thromb. Haemost. 6, 1405-1412 (2008). (Pubitemid 352016322)
    • (2008) Journal of Thrombosis and Haemostasis , vol.6 , Issue.8 , pp. 1405-1412
    • Urbanus, R.T.1    Pennings, M.T.T.2    Derksen, R.H.W.M.3    De Groot, P.G.4
  • 55
    • 39549086338 scopus 로고    scopus 로고
    • Anti-heparin platelet factor 4 antibodies in systemic lupus erythaematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome
    • DOI 10.1136/ard.2007.074476
    • Alpert D, Mandl L, Erkan D, Yin W, Peerschke W, Salmon J: Anti-heparin platelet factor 4 antibodies in systemic lupus erythaematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome. Ann. Rheum. Dis. 67, 395-401 (2008). (Pubitemid 351281277)
    • (2008) Annals of the Rheumatic Diseases , vol.67 , Issue.3 , pp. 395-401
    • Alpert, D.1    Mandl, L.A.2    Erkan, D.3    Yin, W.4    Peerschke, E.I.5    Salmon, J.E.6
  • 56
    • 33847371134 scopus 로고    scopus 로고
    • High prevalence of antibodies to platelet factor 4 heparin in patients with antiphospholipid antibodies in absence of heparin-induced thrombocytopenia
    • DOI 10.1177/0961203306075562
    • Martin-Toutain I, Piette J, Diemert M, Faucher C, Jobic L, Ankri A: High prevalence of antibodies to platelet factor 4 heparin in patients with antiphospholipid syndrome in absence of heparin-induced thrombocytopenia. Lupus 16, 79-83 (2007). (Pubitemid 46347928)
    • (2007) Lupus , vol.16 , Issue.2 , pp. 79-83
    • Martin-Toutain, I.1    Piette, J.C.2    Diemert, M.C.3    Faucher, C.4    Jobic, L.5    Ankri, A.6
  • 57
    • 77449133188 scopus 로고    scopus 로고
    • B2 glycoprotein I b2GPI binds platelet factor 4 PF4: Implications for the pathogenesis of antiphospholipid syndrome
    • Sikara M, Routsias J, Samiotaki M, Panayotou G, Moutsopoulos H, Vlachoyiannopoulos P: b2 glycoprotein I (b2GPI) binds platelet factor 4 (PF4): implications for the pathogenesis of antiphospholipid syndrome. Blood 115, 713-723 (2010).
    • (2010) Blood , vol.115 , pp. 713-723
    • Sikara, M.1    Routsias, J.2    Samiotaki, M.3    Panayotou, G.4    Moutsopoulos, H.5    Vlachoyiannopoulos, P.6
  • 59
    • 54049157838 scopus 로고    scopus 로고
    • Altered gene expression patterns in dendritic cells after severe trauma: Implications for systemic inflammation and organ injury
    • Maier M, Wutzler S, Bauer M, Trendafilov P, Henrich D, Marzi I: Altered gene expression patterns in dendritic cells after severe trauma: implications for systemic inflammation and organ injury. Shock 30, 344-351 (2008).
    • (2008) Shock , vol.30 , pp. 344-351
    • Maier, M.1    Wutzler, S.2    Bauer, M.3    Trendafilov, P.4    Henrich, D.5    Marzi, I.6
  • 61
    • 0033586656 scopus 로고    scopus 로고
    • Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo
    • Pierangeli S, Colden-Stanfield M, Liu X, Barker J, Anderson G, Harris E: Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo. Circulation 99, 1997-2002 (1999). (Pubitemid 29183897)
    • (1999) Circulation , vol.99 , Issue.15 , pp. 1997-2002
    • Pierangeli, S.S.1    Colden-Stanfield, M.2    Liu, X.3    Barker, J.H.4    Anderson, G.L.5    Harris, E.N.6
  • 62
    • 34948885608 scopus 로고    scopus 로고
    • C5a receptor-deficient mice are protected from thrombophilia and endothelial cell activation induced by some antiphospholipid antibodies
    • DOI 10.1196/annals.1422.058, Autoimmunity, Part D: Autoimmune Disease, Annus Mirabilis
    • Romay-Penabad Z, Liu X, Montiel-Manzano G, de Martinez E, Pierangeli S: C5a receptor-deficient mice are protected from thrombophilia and endothelial cell activation induced by some antiphospholipid antibodies. Ann. NY Acad. Sci. 1108, 554-566 (2007). (Pubitemid 47528769)
    • (2007) Annals of the New York Academy of Sciences , vol.1108 , pp. 554-566
    • Romay-Penabad, Z.1    Liu X, X.2    Montiel-Manzano, G.3    De Martinez, E.P.4    Pierangeli, S.S.5
  • 63
    • 54449091353 scopus 로고    scopus 로고
    • Immunological features of primary anti-phospholipid syndrome in connection with endothelial dysfunction
    • Soltesz P, Der H, Veres K et al.: Immunological features of primary anti-phospholipid syndrome in connection with endothelial dysfunction. Rheumatology 47, 1628-1634 (2008).
    • (2008) Rheumatology , vol.47 , pp. 1628-1634
    • Soltesz, P.1    Der, H.2    Veres, K.3
  • 64
    • 75349108595 scopus 로고    scopus 로고
    • Patients with antiphospholipid syndrome display endothelial perturbation
    • Cugno M, Borghi M, Lonati L et al.: Patients with antiphospholipid syndrome display endothelial perturbation. J. Autoimmunity 34, 105-110 (2010).
    • (2010) J. Autoimmunity , vol.34 , pp. 105-110
    • Cugno, M.1    Borghi, M.2    Lonati, L.3
  • 65
    • 77952946073 scopus 로고    scopus 로고
    • Arterial and venous thrombosis is associated with different angiogenic cytokine patterns in patients with antiphospholid syndrome
    • Smadja D, Gaussem P, Roncal C, Fischer AM, Emmerich J, Darnige L: Arterial and venous thrombosis is associated with different angiogenic cytokine patterns in patients with antiphospholid syndrome. Lupus 19(7), 837-843 (2010).
    • (2010) Lupus , vol.19 , Issue.7 , pp. 837-843
    • Smadja, D.1    Gaussem, P.2    Roncal, C.3    Fischer, A.M.4    Emmerich, J.5    Darnige, L.6
  • 66
    • 67649502333 scopus 로고    scopus 로고
    • Antiphospholipid antibodies may impair factor-XIIa-dependent activation of fibrinolysis in pregnancy: In vitro evidence with human endothelial cells in culture and monoclonal anticardiolipin antibodies
    • Lazaro I, Carmona F, Reverter J, Cervera R, Tassies D, Balasch J: Antiphospholipid antibodies may impair factor-XIIa-dependent activation of fibrinolysis in pregnancy: in vitro evidence with human endothelial cells in culture and monoclonal anticardiolipin antibodies. Am. J. Obstet. Gynecol. 201(87), e1-e6 (2009).
    • (2009) Am. J. Obstet. Gynecol. , vol.201 , Issue.87
    • Lazaro, I.1    Carmona, F.2    Reverter, J.3    Cervera, R.4    Tassies, D.5    Balasch, J.6
  • 67
    • 34547218488 scopus 로고    scopus 로고
    • 2GPI-antibody-induced endothelial cell gene expression profiling reveals induction of novel pro-inflammatory genes potentially involved in primary antiphospholipid syndrome
    • DOI 10.1136/ard.2006.063909
    • Hamid C, Norgate K, D'Cruz D et al.: Anti-b2GPI-antibody-induced endothelial cell gene expression profiling reveals induction of novel pro-inflammatory genes potentially involved in primary antiphospholipid syndrome. Ann. Rheum. Dis. 66, 1000-1007 (2007). (Pubitemid 47122310)
    • (2007) Annals of the Rheumatic Diseases , vol.66 , Issue.8 , pp. 1000-1007
    • Hamid, C.1    Norgate, K.2    D'Cruz, D.P.3    Khamashta, M.A.4    Arno, M.5    Pearson, J.D.6    Frampton, G.7    Murphy, J.J.8
  • 68
    • 18644361988 scopus 로고    scopus 로고
    • Involvement of p38 MAPK in the up-regulation of tissue factor on endothelial cells by antiphospholipid antibodies
    • DOI 10.1002/art.21009
    • Vega-Ostertag M, Casper K, Swerlick R, Ferrara D, Harris E, Pierangeli S: Involvement of p38 MAPK in the upregulation of tissue factor on endothelial cells by antiphospholipid antibodies. Arthritis Rheum. 52(5), 1545-1554 (2005). (Pubitemid 40663946)
    • (2005) Arthritis and Rheumatism , vol.52 , Issue.5 , pp. 1545-1554
    • Vega-Ostertag, M.1    Casper, K.2    Swerlick, R.3    Ferrara, D.4    Harris, E.N.5    Pierangeli, S.S.6
  • 70
    • 0035793334 scopus 로고    scopus 로고
    • Thrombogenic effects of antiphospholipid antibodies are mediated by intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and P-selectin
    • Pierangeli S, Espinola R, Liu X, Harris E: Thrombogenic effects of antiphospholipid syndrome antibodies are mediated by intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and P-selectin. Circ. Res. 88, 245-250 (2001). (Pubitemid 32147315)
    • (2001) Circulation Research , vol.88 , Issue.2 , pp. 245-250
    • Pierangeli, S.S.1    Espinola, R.G.2    Liu, X.3    Harris, E.N.4
  • 72
    • 35449001281 scopus 로고    scopus 로고
    • Activated protein C resistance determined with a thrombin generation-based test is associated with thrombotic events in patients with lupus anticoagulants
    • DOI 10.1111/j.1538-7836.2007.02734.x
    • Liestol S, Sandset P, Mowinckel MC, Wisloff F: Activated protein C resistance determined with a thrombin generation-based test is associated with thrombotic events in patients with lupus anticoagulants. J. Thromb. Haemost. 5, 2204-2210 (2007). (Pubitemid 47617872)
    • (2007) Journal of Thrombosis and Haemostasis , vol.5 , Issue.11 , pp. 2204-2210
    • Liestol, S.1    Sandset, P.M.2    Mowinckel, M.-C.3    Wisloff, F.4
  • 73
    • 69549137883 scopus 로고    scopus 로고
    • The role of antiphospholipid antibodies toward the protein C protein S system in venous thromboembolic disease
    • Rossetto V, Spiezia L, Franz F et al.: The role of antiphospholipid antibodies toward the protein C/protein S system in venous thromboembolic disease. Am. J. Hematol. 84(9), 594-596 (2009).
    • (2009) Am. J. Hematol. , vol.84 , Issue.9 , pp. 594-596
    • Rossetto, V.1    Spiezia, L.2    Franz, F.3
  • 74
    • 34250736220 scopus 로고    scopus 로고
    • Autoantibodies against endothelial protein C receptor and the risk of a first deep vein thrombosis
    • DOI 10.1111/j.1538-7836.2007.02582.x
    • van Hylckama Vlieg A, Montes R, Rosendaal F, Hermida J: Autoantibodies against endothelial protein C receptor and the risk of a first deep vein thrombosis. J. Thromb. Haemost. 5, 1449-1454 (2007). (Pubitemid 46965374)
    • (2007) Journal of Thrombosis and Haemostasis , vol.5 , Issue.7 , pp. 1449-1454
    • Van Hylckama Vlieg, A.1    Montes, R.2    Rosendaal, F.R.3    Hermida, J.4
  • 76
    • 33751578678 scopus 로고    scopus 로고
    • Antibodies against the activated coagulation factor X FXa in the antiphospholipid syndrome that interfere with the FXa inactivation by antithrombin
    • Yang Y-H, Hwang K-K, FitzGerald J et al.: Antibodies against the activated coagulation factor X (FXa) in the antiphospholipid syndrome that interfere with the FXa inactivation by antithrombin. J. Immunol. 177(8219), 8225 (2006).
    • (2006) J. Immunol. , vol.177 , Issue.8219 , pp. 8225
    • Yang, Y.-H.1    Hwang, K.-K.2    FitzGerald, J.3
  • 77
    • 63149169674 scopus 로고    scopus 로고
    • Novel autoantibodies against the activated coagulation factor IX FIXa in the antiphospholipid syndrome that interpose the FIXa regulation by antithrombin
    • Yang Y-H, Chien D, Wu M et al.: Novel autoantibodies against the activated coagulation factor IX (FIXa) in the antiphospholipid syndrome that interpose the FIXa regulation by antithrombin. J. Immunol. 182, 1674-1680 (2009).
    • (2009) J. Immunol. , vol.182 , pp. 1674-1680
    • Yang, Y.-H.1    Chien, D.2    Wu, M.3
  • 78
    • 33750020533 scopus 로고    scopus 로고
    • The effects of tissue factor pathway inhibitor and anti-β-2- glycoprotein-I IgG on thrombin generation
    • Lean S, Ellery P, Ivey L et al.: The effects of tissue factor pathway inhibitor and anti-β-2-glycoprotein-I IgG on thrombin generation. Haematologica 91, 1360-1366 (2006) (Pubitemid 44569809)
    • (2006) Haematologica , vol.91 , Issue.10 , pp. 1360-1366
    • Lean, S.Y.1    Ellery, P.2    Ivey, L.3    Thom, J.4    Oostryck, R.5    Leahy, M.6    Baker, R.7    Adams, M.8
  • 79
    • 34548816709 scopus 로고    scopus 로고
    • 2-Glycoprotein I inhibits vonWillebrand factor-dependent platelet adhesion and aggregation
    • DOI 10.1182/blood-2006-10-053199
    • Hulstein J, Lenting P, de Laat B, Derksen R, Fijnheer R, de Groot P: β2-glycoprotein I inhibits von Willebrand factor dependent platelet adhesion and aggregation. Blood 110, 1483-1491 (2007). (Pubitemid 47443963)
    • (2007) Blood , vol.110 , Issue.5 , pp. 1483-1491
    • Hulstein, J.J.J.1    Lenting, P.J.2    De Laat, B.3    Derksen, R.H.W.M.4    Fijnheer, R.5    De Groot, P.G.6
  • 80
    • 62449126466 scopus 로고    scopus 로고
    • Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patients with antiphospholipid antibodies and high fibrinogen levels
    • de la Red G, Tassies D, Espinosa G et al.: Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patients with antiphospholipid antibodies and high fibrinogen levels. Thromb. Haemost. 101, 312-316 (2009).
    • (2009) Thromb. Haemost. , vol.101 , pp. 312-316
    • De La Red, G.1    Tassies, D.2    Espinosa, G.3
  • 81
    • 68049110510 scopus 로고    scopus 로고
    • The effects of phosphatidylserine-dependent antiprothrombin antibody on thrombin generation
    • Sakai Y, Atsumi T, Ieko M et al.: The effects of phosphatidylserine- dependent antiprothrombin antibody on thrombin generation. Arthritis Rheum. 60(8), 2457-2467 (2009).
    • (2009) Arthritis Rheum. , vol.60 , Issue.8 , pp. 2457-2467
    • Sakai, Y.1    Atsumi, T.2    Ieko, M.3
  • 83
    • 33748748970 scopus 로고    scopus 로고
    • A human monoclonal antiprothrombin antibody is thrombogenic in vivo and upregulates expression of tissue factor and E-selectin on endothelial cells
    • DOI 10.1111/j.1365-2141.2006.06283.x
    • Vega-Ostertag M, Liu X, Kwank-Ki H, Chen P, Pierangeli S: A human monoclonal antiprothrombin antibody is thrombogenic in vivo and upregulates expression of tissue factor and E-selectin on endothelial cells. Br. J. Haematol. 135(2), 214-219 (2006). (Pubitemid 44401619)
    • (2006) British Journal of Haematology , vol.135 , Issue.2 , pp. 214-219
    • Vega-Ostertag, M.1    Liu, X.2    Kwan-Ki, H.3    Chen, P.4    Pierangeli, S.5
  • 84
    • 59649088830 scopus 로고    scopus 로고
    • β2-Glycoprotein I is a cofactor for tissue plasminogen activatormediated plasminogen activation
    • Bu C, Gao L, Xie W et al.: β2-glycoprotein I is a cofactor for tissue plasminogen activatormediated plasminogen activation. Arthritis Rheum. 60(2), 559-568 (2009).
    • (2009) Arthritis Rheum. , vol.60 , Issue.2 , pp. 559-568
    • Bu, C.1    Gao, L.2    Xie, W.3
  • 85
    • 77954540087 scopus 로고    scopus 로고
    • Increase in plasma thrombin-activatable fibrinolysis inhibitor may not contribute to thrombotic tendency in antiphospholipid syndrome because of inhibitory potential of antiphospholipid antibodies toward TAFI activation
    • Ieko M, Yoshida M, Naito S et al.: Increase in plasma thrombin-activatable fibrinolysis inhibitor may not contribute to thrombotic tendency in antiphospholipid syndrome because of inhibitory potential of antiphospholipid antibodies toward TAFI activation. Int. J. Haematol. 91, 776-783 (2010).
    • (2010) Int. J. Haematol. , vol.91 , pp. 776-783
    • Ieko, M.1    Yoshida, M.2    Naito, S.3
  • 86
    • 67651205888 scopus 로고    scopus 로고
    • STAT4 single nucleotide polymorphism rs7574865 G T as a risk for antiphospholipid syndrome
    • Horita T, Atusmi T, Yoshida N et al.: STAT4 single nucleotide polymorphism, rs7574865 G/T, as a risk for antiphospholipid syndrome. Ann. Rheum. Dis. 68, 1366-1367 (2009).
    • (2009) Ann. Rheum. Dis. , vol.68 , pp. 1366-1367
    • Horita, T.1    Atusmi, T.2    Yoshida, N.3
  • 87
    • 58849119882 scopus 로고    scopus 로고
    • Pro-inflammatory genotype as a risk factor for aPL-associated thrombosis: Report of a family with multiple anti-phospholipid positive members
    • De Angelis V, Scurati S, Raschi E et al.: Pro-inflammatory genotype as a risk factor for aPL-associated thrombosis: report of a family with multiple anti-phospholipid positive members. J. Autoimmunity 32, 60-63 (2009).
    • (2009) J. Autoimmunity , vol.32 , pp. 60-63
    • De Angelis, V.1    Scurati, S.2    Raschi, E.3
  • 88
  • 89
    • 79954444111 scopus 로고    scopus 로고
    • Increased level of tumor necrosis factor-a in patients with antiphospholipid syndrome: Marker not only of inflammation but also of the prothrombotic state
    • Swadzba J, Iwaniec T, Musial J: Increased level of tumor necrosis factor-a in patients with antiphospholipid syndrome: marker not only of inflammation but also of the prothrombotic state. Rheumatol. Int. 31(3), 307-313 (2009).
    • (2009) Rheumatol. Int. , vol.31 , Issue.3 , pp. 307-313
    • Swadzba, J.1    Iwaniec, T.2    Musial, J.3
  • 93
    • 67650067301 scopus 로고    scopus 로고
    • TLR7 and TLR8 ligands and antiphospholipid antibodies show synergistic effects on the induction of the IL-1b and caspase-1 in monocytes and dendritic cells
    • Hurst J, Prinz N, Lorenz M et al.: TLR7 and TLR8 ligands and antiphospholipid antibodies show synergistic effects on the induction of the IL-1b and caspase-1 in monocytes and dendritic cells. Immunobiology 214, 683-691 (2009).
    • (2009) Immunobiology , vol.214 , pp. 683-691
    • Hurst, J.1    Prinz, N.2    Lorenz, M.3
  • 94
    • 38049023658 scopus 로고    scopus 로고
    • 2-glycoprotein I in patients with antiphospholipid syndrome
    • DOI 10.1182/blood-2007-07-100008
    • Yamaguchi Y, Seta N, Kaburaki J, Kobayashi K, Matsuura E, Matsuura E: Excessive exposure to anionic surfaces maintains autoantibody response to β2-glycoprotein I in patients with antiphospholipid syndrome. Blood 110, 4312-4318 (2007). (Pubitemid 351377796)
    • (2007) Blood , vol.110 , Issue.13 , pp. 4312-4318
    • Yamaguchi, Y.1    Seta, N.2    Kaburaki, J.3    Kobayashi, K.4    Matsuura, E.5    Kuwana, M.6
  • 95
    • 67449159236 scopus 로고    scopus 로고
    • Complement activation in patients with primary antiphospholipid syndrome
    • Oku K, Atsumi T, Bohgaki M et al.: Complement activation in patients with primary antiphospholipid syndrome. Ann. Rheum. Dis. 68, 1030-1035 (2009).
    • (2009) Ann. Rheum. Dis. , vol.68 , pp. 1030-1035
    • Oku, K.1    Atsumi, T.2    Bohgaki, M.3
  • 96
    • 65149101917 scopus 로고    scopus 로고
    • Serum complement activation on heterologous platelets is associated with arterial thrombosis in patients with systemic lupus erythematosus and antiphospholipid syndrome
    • Peerschke E, Yin W, Alpert D, Roubey R, Salmon J, Ghebrehiwet B: Serum complement activation on heterologous platelets is associated with arterial thrombosis in patients with systemic lupus erythematosus and antiphospholipid syndrome. Lupus 18, 530-538 (2009).
    • (2009) Lupus , vol.18 , pp. 530-538
    • Peerschke, E.1    Yin, W.2    Alpert, D.3    Roubey, R.4    Salmon, J.5    Ghebrehiwet, B.6
  • 97
    • 41849106908 scopus 로고    scopus 로고
    • Antiphospholipid syndrome patients display reduced titers of soluble CD21 in their sera irrespective of circulating anti-β2-glycoprotein-I autoantibodies
    • Singh A, Blank M, Shoenfeld Y, Illges H: Antiphospholipid syndrome patients display reduced titers of soluble CD21 in their sera irrespective of circulating anti-β2- glycoprotein-I autoantibodies. Rheumatol. Int. 28, 661-665 (2008).
    • (2008) Rheumatol. Int. , vol.28 , pp. 661-665
    • Singh, A.1    Blank, M.2    Shoenfeld, Y.3    Illges, H.4
  • 99
    • 22244485396 scopus 로고    scopus 로고
    • Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia
    • DOI 10.1002/art.21157
    • Pierangeli S, Girardi G, Vega-Ostertag M, Liu X, Espinola R, Salmon J: Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia. Arthritis Rheum. 52(7), 2120-2124 (2005). (Pubitemid 40994335)
    • (2005) Arthritis and Rheumatism , vol.52 , Issue.7 , pp. 2120-2124
    • Pierangeli, S.S.1    Girardi, G.2    Vega-Ostertag, M.3    Liu, X.4    Espinola, R.G.5    Salmon, J.6
  • 100
    • 77951971046 scopus 로고    scopus 로고
    • The role of defective clearance of apoptotic cells in systemic autoimmunity
    • Munoz L, Lauber K, Schiller M, Manfredi A, Hermann M: The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat. Rev. Rheumatol. 6(5), 280-289 (2010).
    • (2010) Nat. Rev. Rheumatol. , vol.6 , Issue.5 , pp. 280-289
    • Munoz, L.1    Lauber, K.2    Schiller, M.3    Manfredi, A.4    Hermann, M.5
  • 101
    • 33846821657 scopus 로고    scopus 로고
    • Antiphospholipid reactivity against cardiolipin metabolites occurring during endothelial cell apoptosis
    • Alessandri C, Sorice M, Bombardieri M et al.: Antiphospholipid reactivity against cardiolipin metabolites occurring during endothelial cell apoptosis. Arthritis Res. Ther. 8, R180 (2006).
    • (2006) Arthritis Res. Ther. , vol.8
    • Alessandri, C.1    Sorice, M.2    Bombardieri, M.3
  • 102
    • 63149195539 scopus 로고    scopus 로고
    • Anti-endothelial antibodies interfere in apoptotic cell clearance and promote thrombosis in patients with antiphospholipid syndrome
    • Graham A, Ford I, Morrison R, Barker R, Greaves M, Erwig L-P: Anti-endothelial antibodies interfere in apoptotic cell clearance and promote thrombosis in patients with antiphospholipid syndrome. J. Immunol. 182, 1756-1762 (2009).
    • (2009) J. Immunol. , vol.182 , pp. 1756-1762
    • Graham, A.1    Ford, I.2    Morrison, R.3    Barker, R.4    Greaves, M.5    Erwig, L.-P.6
  • 103
    • 70349116054 scopus 로고    scopus 로고
    • Vascular abnormalities paraoxonase activity and dysfunctional HDL in primary antiphospholipid syndrome
    • Charakida M, Besler C, Batuca J et al.: Vascular abnormalities, paraoxonase activity, and dysfunctional HDL in primary antiphospholipid syndrome. JAMA 302(11), 1210-1217 (2009).
    • (2009) JAMA , vol.302 , Issue.11 , pp. 1210-1217
    • Charakida, M.1    Besler, C.2    Batuca, J.3
  • 105
    • 37649024028 scopus 로고    scopus 로고
    • Distinguished effects of antiphospholipid antibodies and anti-oxidized LDL antibodies on oxidized LDL uptake by macrophages
    • Kobayashi K, Tada K, Ueno T et al.: Distinguished effects of antiphospholipid antibodies and anti-oxidized LDL antibodies on oxidized LDL uptake by macrophages. Lupus 16, 929-938 (2007).
    • (2007) Lupus , vol.16 , pp. 929-938
    • Kobayashi, K.1    Tada, K.2    Ueno, T.3
  • 106
    • 34548543161 scopus 로고    scopus 로고
    • 2-glycoprotein I complexes with lipid vesicles in macrophages: Implications on the development of antiphospholipid syndrome
    • DOI 10.1016/j.jaut.2007.07.003, PII S0896841107000820
    • Kajiwara T, Yasuda T, Matsuura E: Intracellular trafficking of β2-glycoprotein I complexes with lipid vesicles in macrophages: implications on the development of antiphospholipid syndrome. J. Autoimmunity 29, 164-173 (2007). (Pubitemid 47385117)
    • (2007) Journal of Autoimmunity , vol.29 , Issue.2-3 , pp. 164-173
    • Kajiwara, T.1    Yasuda, T.2    Matsuura, E.3
  • 107
    • 48049112768 scopus 로고    scopus 로고
    • Antibodies to oxidized LDL β2-glycoprotein I in antiphospholipid syndrome patients with venous and arterial thromboembolism
    • Pengo V, Bison E, Ruffatti A, Iliceto S: Antibodies to oxidized LDL/β2- glycoprotein I in antiphospholipid syndrome patients with venous and arterial thromboembolism. Thromb. Res. 122, 556-559 (2008).
    • (2008) Thromb. Res. , vol.122 , pp. 556-559
    • Pengo, V.1    Bison, E.2    Ruffatti, A.3    Iliceto, S.4
  • 108
    • 3242706212 scopus 로고    scopus 로고
    • Histologic features of placentas and abortion specimens from women with antiphospholipid and antiphospholipis-like syndromes
    • DOI 10.1016/j.placenta.2003.12.006, PII S0143400403003254
    • Van Horn J, Craven C, Wark K, Branch D, Silver R: Histologic features of placentas and abortion specimens from women with antiphospholipid and antiphospholipid-like syndromes. Placenta 25, 642-648 (2004). (Pubitemid 38950318)
    • (2004) Placenta , vol.25 , Issue.7 , pp. 642-648
    • Van Horn, J.T.1    Craven, C.2    Ward, K.3    Branch, D.W.4    Silver, R.M.5
  • 109
    • 0030064150 scopus 로고    scopus 로고
    • Placental changes in a first trimester missed abortion in maternal systemic lupus erythematosus with antiphospholipid syndrome: A case report and review of the literature
    • DOI 10.1016/S0046-8177(96)90377-9
    • Nayar R, Lage J: Placental changes in a first trimester missed abortion in maternal systemic lupus erythematosus with antiphospholipid syndrome: a case report and review of the literature. Hum. Pathol. 27, 201-206 (1996). (Pubitemid 26049477)
    • (1996) Human Pathology , vol.27 , Issue.2 , pp. 201-206
    • Nayar, R.1    Lage, J.M.2
  • 110
    • 0027146697 scopus 로고
    • The effect of immunoglobulin G fractions from patients with lupus anticoagulant on placental prostacyclin and thromboxane production
    • Peaceman A, Rehnberg K: The effect of immunoglobulin G fractions from patients with lupus anticoagulant on placental prostacyclin and thromboxane production. Am. J. Obstet. Gynecol. 169, 1403-1406 (1993). (Pubitemid 24009168)
    • (1993) American Journal of Obstetrics and Gynecology , vol.169 , Issue.6 , pp. 1403-1406
    • Peaceman, A.M.1    Rehnberg, K.A.2
  • 111
    • 0028586742 scopus 로고
    • Reduction of annexin-V placental anticoagulant protein-I on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion
    • Rand J, Wu X, Guller S et al.: Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion. Am. J. Obstet. Gynecol. 171(6), 1566-1572 (1994).
    • (1994) Am. J. Obstet. Gynecol. , vol.171 , Issue.6 , pp. 1566-1572
    • Rand, J.1    Wu, X.2    Guller, S.3
  • 112
    • 0037059463 scopus 로고    scopus 로고
    • Molecular pathogenesis of the antiphospholipid syndrome
    • DOI 10.1161/hh0102.102795
    • Rand J: Molecular pathogenesis of the antiphospholipid syndrome. Circ. Res. 11, 29-37 (2002). (Pubitemid 34074605)
    • (2002) Circulation Research , vol.90 , Issue.1 , pp. 29-37
    • Rand, J.H.1
  • 113
    • 77951217438 scopus 로고    scopus 로고
    • The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: Role in pregnancy losses and thrombosis
    • Rand J, Wu X, Quinn A, Taatjes D: The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: role in pregnancy losses and thrombosis. Lupus 19, 460-469 (2010).
    • (2010) Lupus , vol.19 , pp. 460-469
    • Rand, J.1    Wu, X.2    Quinn, A.3    Taatjes, D.4
  • 115
    • 67650651969 scopus 로고    scopus 로고
    • Antiphospholipid antibodies induce a pro-inflammatory response in first trimester trophoblast via the TLR4 MyD88 pathway
    • Mulla M, Brosens J, Chamley L et al.: Antiphospholipid antibodies induce a pro-inflammatory response in first trimester trophoblast via the TLR4/MyD88 pathway. Am. J. Reprod. Immunol. 62, 96-111 (2009).
    • (2009) Am. J. Reprod. Immunol. , vol.62 , pp. 96-111
    • Mulla, M.1    Brosens, J.2    Chamley, L.3
  • 116
    • 77953039466 scopus 로고    scopus 로고
    • Antiphospholipid antibodies limit trophoblast migration by reducing IL-6 production and STAT3 activity
    • Mulla M, Myrtolli K, Brosens J et al.: antiphospholipid antibodies limit trophoblast migration by reducing IL-6 production and STAT3 activity. Am. J. Reprod. Immunol. 63, 339-348 (2010).
    • (2010) Am. J. Reprod. Immunol. , vol.63 , pp. 339-348
    • Mulla, M.1    Myrtolli, K.2    Brosens, J.3
  • 117
    • 72849110555 scopus 로고    scopus 로고
    • Detailed analysis of peripheral blood natural killer NK cells in women with recurrent miscarriage
    • King K, Smith S, Chapman M, Sacks G: Detailed analysis of peripheral blood natural killer (NK) cells in women with recurrent miscarriage. Hum. Reprod. 25(1), 52-58 (2010).
    • (2010) Hum. Reprod. , vol.25 , Issue.1 , pp. 52-58
    • King, K.1    Smith, S.2    Chapman, M.3    Sacks, G.4
  • 118
    • 34848864591 scopus 로고    scopus 로고
    • High levels of NK cells in the peripheral blood of patients affected with anti-phospholipid syndrome and recurrent spontaneous abortion: A potential new hypothesis
    • DOI 10.1093/rheumatology/kem197
    • Perricone C, De Carolis C, Giacomelli R et al.: High levels of NK cells in the peripheral blood of patients affected with antiphospholipid syndrome and recurrent sponatenous abortion: a potential new hypothesis. Rheumatology 46, 1574-1578 (2007). (Pubitemid 47500573)
    • (2007) Rheumatology , vol.46 , Issue.10 , pp. 1574-1578
    • Perricone, C.1    De Carolis, C.2    Giacomelli, R.3    Zaccari, G.4    Cipriani, P.5    Bizzi, E.6    Perricone, R.7
  • 119
    • 34948903311 scopus 로고    scopus 로고
    • Tissue factor: A link between C5a and neutrophil activation in antiphospholipid antibody-induced fetal injury
    • DOI 10.1182/blood-2007-01-070631
    • Redecha P, Tilley R, Tencati M et al.: Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody induced fetal injury. Blood 110, 2423-2431 (2007). (Pubitemid 47523163)
    • (2007) Blood , vol.110 , Issue.7 , pp. 2423-2431
    • Redecha, P.1    Tilley, R.2    Tencati, M.3    Salmon, J.E.4    Kirchhofer, D.5    Mackman, N.6    Girardi, G.7
  • 120
    • 55849112296 scopus 로고    scopus 로고
    • Neutrophil activation by the tissue factor factor VIIa PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome
    • Redecha P, Franzke C-W, Ruf W, Mackman N, Girardi G: Neutrophil activation by the tissue factor/factor VIIa/ PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome. J. Clin. Immunol. 118(10), 3453-3454 (2008).
    • (2008) J. Clin. Immunol. , vol.118 , Issue.10 , pp. 3453-3454
    • Redecha, P.1    Franzke, C.-W.2    Ruf, W.3    Mackman, N.4    Girardi, G.5
  • 121
    • 77955343208 scopus 로고    scopus 로고
    • Antiphospholipid antibodies affect human endometrial angiogenesis
    • Di Simone N, Di Nicuolo F, D'Ippolito S et al.: Antiphospholipid antibodies affect human endometrial angiogenesis. Biol. Reprod. 83, 212-219 (2010).
    • (2010) Biol. Reprod. , vol.83 , pp. 212-219
    • Di Simone, N.1    Di Nicuolo, F.2    Dippolito, S.3
  • 122
    • 78649289804 scopus 로고    scopus 로고
    • Prolactins role in the pathogenesis of the antiphospholipid syndrome
    • Praprotnik S, Agmon-Levin N, Porat-Katz B et al.: Prolactin's role in the pathogenesis of the antiphospholipid syndrome. Lupus 19(13), 1515-1519 (2010).
    • (2010) Lupus , vol.19 , Issue.13 , pp. 1515-1519
    • Praprotnik, S.1    Agmon-Levin, N.2    Porat-Katz, B.3
  • 123
    • 65349188214 scopus 로고    scopus 로고
    • In vivo inhibition of antiphospholipid antibody-induced pathogenecity utilizing the antigenic target peptide domain of β2-glycoprotein I: Proof of concept
    • Ioannou Y, Romay-Penabad Z, Pericleous C et al.: In vivo inhibition of antiphospholipid antibody-induced pathogenecity utilizing the antigenic target peptide domain of β2- glycoprotein I: proof of concept. J. Thromb. Haemost. 7, 833-842 (2009).
    • (2009) J. Thromb. Haemost. , vol.7 , pp. 833-842
    • Ioannou, Y.1    Romay-Penabad, Z.2    Pericleous, C.3
  • 124
    • 74849122596 scopus 로고    scopus 로고
    • Effect of long-term belimumab treatment on B cells in systemic lupus erythematosus: Extension of a phase II double-blind placebo-controlled dose-ranging study
    • Jacobi A, Huand W, Wang T et al.: Effect of long-term belimumab treatment on B cells in systemic lupus erythematosus: extension of a Phase II, double-blind, placebo-controlled, dose-ranging study. Arthritis Rheum. 62(1), 201-210 (2010).
    • (2010) Arthritis Rheum. , vol.62 , Issue.1 , pp. 201-210
    • Jacobi, A.1    Huand, W.2    Wang, T.3
  • 125
    • 69749120918 scopus 로고    scopus 로고
    • A phase II randomized double-blind placebocontrolled dose-ranging study of belimumab in patients with active systemic lupus erythematosus
    • Wallace D, Stohl W, Furie R et al.: A Phase II, randomized, double-blind, placebocontrolled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus. Arthritis Rheum. 61(9), 1168-1178 (2009).
    • (2009) Arthritis Rheum. , vol.61 , Issue.9 , pp. 1168-1178
    • Wallace, D.1    Stohl, W.2    Furie, R.3
  • 126
    • 77957004137 scopus 로고    scopus 로고
    • B-lymphocyte stimulator a proliferationinducing ligand heterotrimers are elevated in the sera of patients with autoimmune disease and are neutralized by atacicept and B-cell maturation antigen-immunoglobulin
    • Dillon S, Harder B, Lewis K et al.: B-lymphocyte stimulator/a proliferationinducing ligand heterotrimers are elevated in the sera of patients with autoimmune disease and are neutralized by atacicept and B-cell maturation antigen-immunoglobulin. Arthritis Res. Ther. 12(2), R48 (2010).
    • (2010) Arthritis Res. Ther. , vol.12 , Issue.2
    • Dillon, S.1    Harder, B.2    Lewis, K.3
  • 127
    • 51849128320 scopus 로고    scopus 로고
    • Prevention of murine antiphospholipid syndrome by BAFF blockade
    • Kahn P, Ramanujam M, Bethunaickan R et al.: Prevention of murine antiphospholipid syndrome by BAFF blockade. Arthritis Rheum. 58(9), 2824-2834 (2008).
    • (2008) Arthritis Rheum. , vol.58 , Issue.9 , pp. 2824-2834
    • Kahn, P.1    Ramanujam, M.2    Bethunaickan, R.3
  • 128
    • 76049120027 scopus 로고    scopus 로고
    • Pharmacokinetics of LJP 993 a tetrameric conjugate of domain 1 of β2-glycoprotein I for antiphospholipid syndrome
    • Jia L, Gu Y, Zeng E, Linnik M, Jones D: Pharmacokinetics of LJP 993, a tetrameric conjugate of domain 1 of β2-glycoprotein I for antiphospholipid syndrome. Lupus 19(2), 130-137 (2010).
    • (2010) Lupus , vol.19 , Issue.2 , pp. 130-137
    • Jia, L.1    Gu, Y.2    Zeng, E.3    Linnik, M.4    Jones, D.5
  • 130
    • 0029990745 scopus 로고    scopus 로고
    • Hydroxychloroquine use in the Baltimore Lupus Cohort: Effects on lipids, glucose and thrombosis
    • Petri M: Hydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipid, glucose and thrombosis. Lupus 5(Suppl. 1), S16-S22 (1996). (Pubitemid 26196736)
    • (1996) Lupus , vol.5 , Issue.SUPPL. 1
    • Petri, M.1
  • 131
    • 0031442025 scopus 로고    scopus 로고
    • Hydroxychloroquine reverses thrombogenic properties of antiphospholipid antibodies in mice
    • Edwards M, Pierangeli S, Liu X, Barker J, Anderson G, Harris E: Hydroxochloroquine reverses thrombogenic properties of antiphospholipid antibodies in mice. Circulation 96(12), 4380-4384 (1997). (Pubitemid 28007469)
    • (1997) Circulation , vol.96 , Issue.12 , pp. 4380-4384
    • Edwards, M.H.1    Pierangeli, S.2    Liu, X.3    Barker, J.H.4    Anderson, G.5    Nigel Harris, E.6
  • 133
    • 0242721975 scopus 로고    scopus 로고
    • Inhibition of the Thrombogenic and Inflammatory Properties of Antiphospholipid Antibodies by Fluvastatin in an In Vivo Animal Model
    • DOI 10.1002/art.11449
    • Ferrara D, Liu X, Espinola R et al.: Inhibition of the thrombogenic and inflammatory properties of antiphospholipid antibodies by fluvastatin in an in vivo animal model. Arthritis Rheum. 48(11), 3272-3279 (2003). (Pubitemid 37409342)
    • (2003) Arthritis and Rheumatism , vol.48 , Issue.11 , pp. 3272-3279
    • Ferrara, D.E.1    Liu, X.2    Espinola, R.G.3    Meroni, P.L.4    Abukhalaf, I.5    Harris, E.N.6    Pierangeli, S.S.7
  • 136
    • 75749127860 scopus 로고    scopus 로고
    • Improved pain physical functioning and health status in patients with rheumatoid arthritis treated with CP-690 550 an orally active Janus kinase JAK
    • Coombs J, Bloom B, Breedveld F et al.: Improved pain, physical functioning and health status in patients with rheumatoid arthritis treated with CP-690,550, an orally active Janus kinase (JAK) inhibitor: results from a randomized, double-blind placebo controlled trial. Ann. Rheum. Dis. 69(2), 413-416 (2010).
    • (2010) Ann. Rheum. Dis. , vol.69 , Issue.2 , pp. 413-416
    • Coombs, J.1    Bloom, B.2    Breedveld, F.3
  • 137
    • 67650093218 scopus 로고    scopus 로고
    • The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind placebo-controlled phase IIa trial of three dosage levels of CP-690 550 versus placebo
    • Kremer J, Bloom B, Breedveld F et al.: The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled Phase IIa trial of three dosage levels of CP-690,550 versus placebo. Arthritis Rheum. 60(7), 1895-1905 (2009).
    • (2009) Arthritis Rheum. , vol.60 , Issue.7 , pp. 1895-1905
    • Kremer, J.1    Bloom, B.2    Breedveld, F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.